Job Description

Advanced Clinical Speciality Fellowship (Haematology)



Applications are invited to apply for this exciting opportunity to work within a large, dynamic trials unit looking after haematology patients. It is a 1-year fixed term post on the Haematology Trials Unit at the Department of Oncology and Haematology.



The post holders will develop advanced specialist experience in a specific disease site with a focus on advanced cellular and molecular therapies. Post holders will be responsible for the day-to-day management patients having advanced medicinal therapies, including cellular , and complex advanced therapy combinations. Essential experience in either haematology or oncology includes; satisfactory clinical specialty training to a senior level, a completed higher research degree (PhD/DPhil) and experience of the management of acute complications of advanced treatments. Training will focus on the design, establishment and execution of advanced therapy clinical trials, including grant applications and presentations/ publications of research results. The posts are not suitable for support of a higher degree and are focused on advanced clinical experience prior to appointment at Consultant/ Clinical Professor/ Senior Clinical Research Fellow level.



The post holder will be responsible for the day-to-day management of patients with haematological malignancy on the Haematology Trials Unit. There will be an opportunity to develop research projects in clinical trials and translational science, and training will focus on the design, setting up and execution of clinical research.



The post is available from October 2025.



Candidates are invited to contact Professor Paresh Vyas, Professor of Haematology and Honorary Consultant Haematologist, Haematology Clinical Lead (0781 724 8950); Dr Toby Eyre, Consultant Haematologist, Haematology Deputy Clinical Lead; (07728 268414)



To apply and gain further details of this post , go to 'NHS Jobs'. Please apply via this website .



In the interest of equal opportunities, we want to make sure that information about candidates is provided in the same format so all applicants should fill in the standard application form on the NHS Jobs website.



Oxford University Hospitals NHS Foundation Trust is one of the largest NHS teaching trusts in the country. It provides a wide range of general and specialist clinical services and is a base for medical education, training and research. The Trust comprises four hospitals - the John Radcliffe Hospital, Churchill Hospital and Nuffield Orthopaedic Centre in Headington and the Horton General Hospital in Banbury.



Our values, standards and behaviours define the quality of clinical care we offer and the professional relationships we make with our patients, colleagues and the wider community.



We call this Delivering Compassionate Excellence, and its focus is on our values of compassion, respect, learning, delivery, improvement and excellence.



These values put patients at the heart of what we do and underpin the quality healthcare we would like for ourselves or a member of our family. Watch how we set out to deliver compassionate excellence via the OUH YouTube channel .



In 2023 NHS England launched its first sexual safety charter, and our Trust proudly signed it. We pledge zero tolerance for inappropriate sexual behaviour and commit to the ten core principles



Oxford University Hospital s promotes a safe, respectful hiring environment.



If you want to make a difference with us, come and join our team. Together, we will uphold the highest standards of care and professionalism.

Clinical and Research Responsibilities:

Inpatient and outpatient care of haematological cancer patients being treated as part of trials performed on the Haematology trial Unit and selected trials being run through the late phase trials team.



In close collaboration with a dedicated senior clinical-academic mentor, the Advanced fellow will select a major research project question, lasting the two years. This may include new clinical trial design and development, data analysis of a unique large database, or pursuing a translational project with clinical outcomes in collaboration with a research laboratory or industry. The ACSF will be expected to present this proposal early in the post to the ACSF senior panel, including external advisors, industry colleagues for peer review and evaluation. In addition, smaller projects with discrete and more rapid outcomes may be completed, e.g. descriptive clinical papers. It is expected that all research findings will be communicated at national and international conferences, result in publications communicated to patients and stakeholders.



It is expected that ACSFs will be outstanding clinicians and fully contribute to clinical care, clinical decision making, team-based activity and clinical leadership. A fixed timetable of activity will be developed that includes multi-disciplinary meetings and clinical practice. All ACSFs will participate in general oncology and haematology acute services, such as management of acute emergencies and complications from treatment. These will be limited and on a rotational basis. In addition, experience in service development of advanced therapies specifically will be encouraged as a leadership experience is seen as an essential component of the unique training offered.



Preparation of results for publication.



Please see attached for more details and weekly timetable